Literature DB >> 25737972

The evaluation of serum levels of testosterone in type 2 diabetic men and its relation with lipid profile.

Nirmali Mattack1, Runi Devi2, Tridip Kutum1, Dibyaratna Patgiri3.   

Abstract

INTRODUCTION AND AIM: Type 2 diabetes mellitus (T2DM) is the predominant form of diabetes worldwide and much is known about its patho-physiology. Yet, newer aspects related to it are being constantly explored. For ages, testosterone has been known to men as the male sex hormone but now it has been shown by certain studies that it might have a role in the development of metabolic disorders like type 2 diabetes. This study was carried out to determine the relation of testosterone levels with type 2 diabetes mellitus and lipid profile in North East Indian men aged 31 to 73 years.
MATERIALS AND METHODS: This case control study comprised of 40 type 2 diabetic men and 40 age matched non diabetic healthy men. Testosterone, SHBG levels and lipid profile were evaluated in both the groups along with anthropometric measurements and were statistically analysed.
RESULTS: Serum total and free testosterone and Sex Hormone Binding Globulin were significantly lower in the test group than in the control group. Prevalence of type 2diabetes was five times higher in men having a total testosterone less than 8nmol/L and 5.57 times higher in those having a free testosterone of less than 0.225nmol/L. Fasting blood glucose showed a strong negative correlation with total and free testosterone. Glycated haemoglobin correlated negatively with SHBG but no such correlation was seen with total or free testosterone. Serum total and LDL cholesterol showed significant negative correlation with total testosterone and SHBG but no significant correlation was found with free testosterone. Serum VLDL, HDL and triglycerides did not show any significant correlation with total or free testosterone and SHBG levels.
CONCLUSION: Low testosterone might have a role in the development of type 2 DM and to the associated altered lipid profile. This study, though a small one is among the few of its kind in India and it thrives to assist other studies related to the matter.

Entities:  

Keywords:  Dyslipidemia; Serum free testosterone; Serum total testosterone; Sex hormone binding globulin; Type 2 diabetes

Year:  2015        PMID: 25737972      PMCID: PMC4347063          DOI: 10.7860/JCDR/2015/11049.5381

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  30 in total

1.  Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine.

Authors:  J A Lott; K Turner
Journal:  Clin Chem       Date:  1975-11       Impact factor: 8.327

2.  Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study.

Authors:  Kay-Tee Khaw; Mitch Dowsett; Elizabeth Folkerd; Sheila Bingham; Nicholas Wareham; Robert Luben; Ailsa Welch; Nicholas Day
Journal:  Circulation       Date:  2007-11-26       Impact factor: 29.690

3.  Monoclonal antibodies to human sex hormone-binding globulin (SHBG): characterization and use in a simple enzyme-linked immunosorbent assay (ELISA) of SHBG in plasma.

Authors:  J G Lewis; N J Longley; P A Elder
Journal:  Steroids       Date:  1999-04       Impact factor: 2.668

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

Review 6.  Diabetes mellitus and hypertension.

Authors:  M Epstein; J R Sowers
Journal:  Hypertension       Date:  1992-05       Impact factor: 10.190

7.  Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study.

Authors:  S A Paul Chubb; Zoë Hyde; Osvaldo P Almeida; Leon Flicker; Paul E Norman; Konrad Jamrozik; Graeme J Hankey; Bu B Yeap
Journal:  Eur J Endocrinol       Date:  2008-06       Impact factor: 6.664

8.  Testosterone concentrations in women and men with NIDDM.

Authors:  B Andersson; P Mårin; L Lissner; A Vermeulen; P Björntorp
Journal:  Diabetes Care       Date:  1994-05       Impact factor: 19.112

9.  Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.

Authors:  S M Haffner; J Shaten; M P Stern; G D Smith; L Kuller
Journal:  Am J Epidemiol       Date:  1996-05-01       Impact factor: 4.897

10.  Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study.

Authors:  Atsushi Goto; Akemi Morita; Maki Goto; Satoshi Sasaki; Motohiko Miyachi; Naomi Aiba; Yasuo Terauchi; Mitsuhiko Noda; Shaw Watanabe
Journal:  Cardiovasc Diabetol       Date:  2012-10-16       Impact factor: 9.951

View more
  4 in total

1.  Erectile Dysfunction and Low Sex Drive in Men with Type 2 DM: The Potential Role of Diabetic Pharmacotherapy.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Clin Diagn Res       Date:  2016-12-01

2.  Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells.

Authors:  Chong Feng; Zhen Jin; Lei Sun; Xiaoyan Wang; Xinshu Chi; Xuan Zhang; Siyu Lian
Journal:  Mol Biol Rep       Date:  2019-07-03       Impact factor: 2.316

3.  Serum free testosterone level in coronary artery disease in candidates for coronary artery bypass graft surgery: A cross-sectional study.

Authors:  Shahriar Mali; Kurosh Irani; Seyed Mohammad Mohammadi; Mohammadtaghi Sarebanhassanabadi
Journal:  Int J Reprod Biomed       Date:  2021-03-21

4.  SLC35B4, an Inhibitor of Gluconeogenesis, Responds to Glucose Stimulation and Downregulates Hsp60 among Other Proteins in HepG2 Liver Cell Lines.

Authors:  Brigitte Wex; Rémi M Safi; Gregory Antonios; Perla Z Zgheib; Dania B Awad; Firas H Kobeissy; Rami A Mahfouz; Marwan M El-Sabban; Soha N Yazbek
Journal:  Molecules       Date:  2018-06-04       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.